Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04905056
PHASE2
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
Sponsor: Shanghai Zhongshan Hospital
View on ClinicalTrials.gov
Summary
A prospective, two-center, single arm phase II clinical study to evaluate safety and effectiveness of ablation therapy in the treatment of lung cancer presenting as ground-glass nodules
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2021-01-01
Completion Date
2028-12-31
Last Updated
2021-05-27
Healthy Volunteers
No
Conditions
Interventions
OTHER
Ablation therapy
Ablation therapy in the treatment of lung cancer presenting as ground-glass nodules
Locations (1)
Department of Thoracic Surgery, Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China